logo
Centre agrees to 48-hour work week for resident doctors after first scheme review in 33 years

Centre agrees to 48-hour work week for resident doctors after first scheme review in 33 years

NEW DELHI: For the first time in 33 years, the Centre on Tuesday held a high-level meeting to review and update the Central Residency Scheme, 1992, and accepted the long-pending demand to fix the duty hours of resident doctors to 48 hours per week.
The meeting was chaired by Dr Sunita Sharma, the newly appointed Additional Director General of Health Services (DGHS), and attended by directors of all major Delhi-based government hospitals, members of the Indian Medical Association (IMA), and representatives from leading resident doctors' associations including FAIMA, FORDA, UDF, and IMA-JDN.
'We held the first meeting today and discussed various issues. We will meet again,' Dr Atul Goel, Director General of Health Services, told this paper.
He added that no final decisions were made during the meeting and the ministry would take a final call on the recommendations.
However, several resident doctor associations claimed that their key demand, a fixed 48-hour work week for both junior and senior resident doctors, was accepted during the discussion.
Welcoming the move, Dr Rohan Krishnan, chief patron of the Federation of All India Medical Association (FAIMA), said, 'One of the crucial issues was the long working hours of senior and junior resident doctors. We had proposed that it should not exceed 48 hours a week with at least one off every week on a rotation basis. The ministry accepted this.'
He added, 'The Central Residency Scheme has not been revised since 1992. We feel resident doctors will be more comfortable in a safe working environment, leading to better patient care. If the basic needs of resident doctors are met, then I think there would be better care for the patients.'
Dr Krishnan said FAIMA had raised the demand for a scheme review following the tragic incident at RG Kar Medical College, where a postgraduate doctor was brutally raped and murdered in a government hospital in Kolkata last year.
Dr Lakshya Mittal, National President of the United Doctors' Front (UDF), posted on X, calling the development a big win for resident doctors. 'After today's DGHS meeting, it is confirmed 48 hours/week fixed duty hours will replace the vague term 'reasonable',' he said, adding that allowance revisions were also approved.
Dr Dhruv Chauhan, National Spokesperson for the Indian Medical Association–Junior Doctors Network (IMA-JDN), said, 'It was a fruitful meeting, and they have taken note of all the concerns we raised, including ensuring 48 hours/week fixed duty hours for all resident doctors.'
'Allowances revision for doctors and fixed amounts for thesis and books were also approved in the meeting and taken further for implementation,' he told this paper.
In addition to duty hours, the meeting addressed a wide range of concerns including hostel facilities, thesis grants, assistant professor salaries, and health benefits for postgraduate and senior resident doctors.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Advent to invest $175 million in Felix Pharma to acquire minority stake
Advent to invest $175 million in Felix Pharma to acquire minority stake

The Hindu

timean hour ago

  • The Hindu

Advent to invest $175 million in Felix Pharma to acquire minority stake

Advent, a private equity investor, has announced that funds managed by it have signed a definitive agreement to invest $175 million via primary and secondary capital for a significant minority stake in Dublin, Ireland-based Felix Pharmaceuticals Pvt. Ltd. (Felix), a global Gx animal pharma player. Felix Pharma is one of the developers and manufacturer of off-patent medicines for companion animals. Felix develops, manufactures and supplies to distributors and other branded Gx players for private labelling, particularly in the U.S. Shweta Jalan, Managing Partner, Advent, said, 'Healthcare has been a long-standing focus for us, and strong parallels we see between success in human Gx globally and emerging opportunity in animal health Gx. Felix is well positioned to lead this space with its strong leadership, broad portfolio, and robust R&D and commercial capabilities.' 'Its rapid growth and high customer satisfaction make it a differentiated platform, and we are excited to support Neeraj and the Felix team in scaling it into a global franchise,' she added, Founded in 2015 by Neeraj Agrawal, a McKinsey alum, Sir Jonathan Symonds, Chair of GSK and with 30 years of experience in global pharmaceuticals, and Dr. Shumeet Banerji, ex-CEO of Booz-Allen, Felix said it has pursued strategic growth through a disciplined approach, While the company achieved its first U.S. FDA approval in 2020, it has quickly scaled to a 14 commercialised product portfolio and has several others in advanced stages of pipeline. It has a USFDA-approved oral solid facility dedicated to animal health products and an injectable facility that is expected to be ready by Q3 2025. Neeraj Agrawal, Co-Founder, Felix Pharma, said, 'As we scale in a fast-evolving market, we were looking for a partner who brings not just capital, but also deep operating expertise and the right mindset and networks to help us grow faster and stronger. Advent's strong track record in healthcare and pharma, and their close involvement in building strong businesses, gives us great confidence.'

Ahmedabad reports highest single-day rise in Covid cases; state's active case tally at 1,109
Ahmedabad reports highest single-day rise in Covid cases; state's active case tally at 1,109

Indian Express

time2 hours ago

  • Indian Express

Ahmedabad reports highest single-day rise in Covid cases; state's active case tally at 1,109

With 131 new cases of Covid in Ahmedabad — the highest single-day rise in the city — the state recorded 235 new cases on Monday. Ahmedabad Municipal Corporation's (AMC's) health officials confirmed that Monday's was the highest number of Covid cases that the city has reported in 24 hours after the fresh spate of cases. The total number of active cases in the state stands at 1,109, including 33 people who needed hospitalisation. Others are undergoing OPD-based treatment. Another 106 people, who recovered from the virus, were discharged on Monday. As per a health bulletin released by the state government, no death was reported in Gujarat on Monday. In Ahmedabad, the tally of cases has gone up to 916, including 646 active. Ahmedabad city has reported two deaths due to Covid. Among the active cases in Ahmedabad, highest were reported in the the west zone at 211, followed by the north west zone at 204, and south west zone at 114. The remaining zones have reported 50 (south zone), 25 (north zone), 24 (east zone), 18 (central zone) cases. According to the Indian SARS-CoV-2 Genomics Consortium (INSACOG), the XFG variant of the Covid-19 has been recently found in a total of 163 samples — with the highest (89) in Maharashtra, followed by Tamil Nadu (16), Kerala (15), Gujarat (11), and Andhra Pradesh, Madhya Pradesh and West Bengal (6 each). The recombinant XFG variant harbours four key spike mutations and has achieved rapid global spread following its initial detection in Canada, according to an article in The Lancet journal. In May, as many as 159 samples were detected with XFG variant, two in April, and two in June yet, data shows. India's active Covid case tally crossed the 6,000 mark, with 769 having been added to it in 48 hours, according to Union Health Ministry data released on Sunday

Luxury skincare expansion: L'Oreal acquires majority stake in Medik8; announces 1 billion Euro deal
Luxury skincare expansion: L'Oreal acquires majority stake in Medik8; announces 1 billion Euro deal

Time of India

time3 hours ago

  • Time of India

Luxury skincare expansion: L'Oreal acquires majority stake in Medik8; announces 1 billion Euro deal

Cosmetics maker L'Oreal agreed to acquire a majority stake in British skincare brand Medik8, in a strategic move to strengthen its presence in the booming skincare market. The French beauty giant announced the deal on Monday, though financial terms were not disclosed. The transaction, which sees UK-based private equity firm Inflexion selling its majority holding, reportedly values Medik8 at around 1 billion Euro, according to a source familiar with the matter. Inflexion will retain a minority share, while L'Oreal has secured the option to eventually buy out all remaining shareholders, Reuters reported. 'We are delighted to welcome Medik8 to the L'Oréal family. As a premium skincare range, with high levels of proven efficacy at an accessible price point, Medik8 perfectly complements our existing skincare portfolio,' Cyril Chaupuy, president of L'oreal Luxe said. 'This acquisition further strengthens L'Oreal's luxe portfolio, adding a premium science-backed skincare brand with a proven track record of success, with strong potential for global growth,' the company said in a statement. L'Oreal will begin consolidating Medik8's sales once the transaction officially closes. The acquisition is expected to be finalised in the coming months, pending regulatory approvals and standard closing conditions. Simon Coble, CEO of Medik8 also expressed excitement on the brand's behalf. 'I am delighted to be joining forces with a company which shares our vision for the brand's future growth and whose core values align with our deep commitment to science, innovation and above all, results without compromise. I look forward to the next stage in Medik8's journey, as we work together to bring our innovative products to a wider audience.' Founded in the UK, Medik8 has built a loyal customer base with its vitamin A-focused anti-ageing creams and serums. The brand is seen as a natural fit for L'Oreal's luxury division, which includes skincare and fragrance names such as Lancome, Aesop, and Miu Miu. Last year, sales in L'Oreal's luxe segment grew by just 2.7%, its weakest performance across divisions, as inflation pushed consumers toward more affordable alternatives. However, the unit scrored better than rival LVMH's beauty arm. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store